BONISTA CARTRIDGE VAIL

About

BONISTA CARTRIDGE contains teriparatide, a recombinant form of human parathyroid hormone (PTH). Unlike antiresorptive agents that primarily inhibit bone breakdown, teriparatide acts as a potent anabolic agent, directly stimulating osteoblasts, the bone-forming cells. When administered intermittently, it promotes new bone formation on both trabecular and cortical bone surfaces, leading to a significant increase in bone mineral density and improved bone microarchitecture. This unique mechanism of action helps to rebuild bone tissue, enhance bone strength, and substantially reduce the risk of fragility fractures in patients with severe osteoporosis. It is typically prescribed for individuals at high risk of fracture who have not responded to or cannot tolerate other osteoporosis treatments, offering a powerful and distinct option for bone regeneration and fracture prevention in severe cases.

Uses

• Treatment of severe osteoporosis in postmenopausal women
• Treatment of severe osteoporosis in men
• Management of glucocorticoid-induced osteoporosis
• For patients at high risk of fracture

Directions For Use

Administer subcutaneously once daily using the pre-filled pen device, as instructed by your healthcare provider.

Benefits

• Stimulates new bone formation
• Significantly reduces the risk of fractures
• Increases bone mineral density
• Improves bone microarchitecture
• Effective in severe osteoporosis cases
• Offers a unique anabolic approach to bone health

Side Effects

• Nausea
• Dizziness
• Leg cramps
• Headache
• Joint pain
• Injection site reactions
• Hypercalcemia
• Hypotension
• Asthenia
• Depression
• Vertigo
• Palpitation

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol consumption can negatively impact bone health.
• Pregnancy - Contraindicated during pregnancy due to potential for fetal harm.
• Breastfeeding - Contraindicated; it is unknown if teriparatide is excreted in human milk.
• Liver - Use with caution in patients with liver impairment; no specific dose adjustment usually needed.
• Kidney - Use with caution in moderate renal impairment; contraindicated in severe renal impairment.
• Lung - No direct impact on lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.